News Releases

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
8/23/2017
7:30 AM ET
Press Release

Diffusion Pharmaceuticals Names William Hornung Chief Business Officer

8/23/2017

CHARLOTTESVILLE, Va., Aug. 23, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc.(NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on the development...

 Continue Reading
8/14/2017
4:01 PM ET
Press Release

Diffusion Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update

8/14/2017

CHARLOTTESVILLE, Va., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc.(NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on the development...

 Continue Reading
7/31/2017
8:30 AM ET
Press Release

Diffusion Pharmaceuticals Selects Contract Research Organization for Phase 3 Clinical Trial of Lead Compound TSC for Inoperable GBM Brain Cancer

7/31/2017

CHARLOTTESVILLE, Va., July 31, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN), a clinical stage biotechnology company developing novel small molecule therapeutics for cancer...

 Continue Reading
7/20/2017
8:30 AM ET
Press Release

Diffusion Pharmaceuticals Achieves Drug Production Milestone For Planned Phase 3 Clinical Trial In Inoperable GBM Brain Cancer

7/20/2017

CHARLOTTESVILLE, Va., July 20, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company developing novel small molecule therapeutics for cancer a...

 Continue Reading
7/6/2017
8:00 AM ET
Press Release

Diffusion Pharmaceuticals Appoints Dr. Robert Ruffolo to Board of Directors

7/6/2017

CHARLOTTESVILLE, Va., July 06, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therap...

 Continue Reading
5/15/2017
4:05 PM ET
Earnings Release

Diffusion Pharmaceuticals Provides Corporate Highlights and Reports Financial First Quarter 2017 Results

5/15/2017

CHARLOTTESVILLE, Va., May 15, 2017 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN), a clinical stage biotechnology company focused on the development of novel small molecule therape...

 Continue Reading
Displaying 1 to 7 (of 80 releases)